MAPT and Alzheimer disease: However, there is accumulating evidence that tau hyperphosphoralisation is increased and prevalent in AD [7], which impairs tau binding to micro-tubules, and enables its combination into oligomers, which are thought to be most toxic, and its aggregation into filaments or fibrils [8].